(Senior) Medical Science Liaison - Heartland

Indiana, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical Devices, BiotechnologyIndustries

Requirements

Candidates should possess an advanced scientific or medical degree, such as a PhD, PharmD, MD, MSN, or BSN, and demonstrate a basic understanding of oncology, with a strong preference for familiarity with molecular testing. Applicants should have at least one year of MSL experience in diagnostics, biotech, or pharmaceutical industries, and a foundational understanding of oncology, as well as a basic understanding of molecular testing. Knowledge of genomic laboratory-developed testing (LDT), CLIA-88’, CAP, and the Sunshine Act (2013) is preferred, along with existing relationships with key opinion leaders (KOLs) in oncology.

Responsibilities

The Senior Medical Science Liaison will function as a sales and commercial team support and a regional expert regarding Tempus oncology assays, promoting the exchange of clinical/scientific/technical information with regional KOLs and other physicians in the field of oncology. They will facilitate education of a broader healthcare provider community within the region (KOLs, community physicians, medical directors, and other HCPs) regarding Tempus oncology products via in-person or virtual presentations, proactively and reactively sharing scientific data. The MSL will provide scientific education for internal stakeholders in collaboration with the Learning & Development team, attend conferences and provide comprehensive meeting synopses, and continuously update internal stakeholders on relevant medical and scientific knowledge as well as proactively sharing market intelligence.

Skills

oncology

genomic testing

clinical communication

scientific education

conference presentation

market intelligence

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free